ES2052020T3 - Antibioticos efectivos frente a bacterias anaerobias, su produccion y utilizacion y cepas de enterobacter productoras de los mismos. - Google Patents

Antibioticos efectivos frente a bacterias anaerobias, su produccion y utilizacion y cepas de enterobacter productoras de los mismos.

Info

Publication number
ES2052020T3
ES2052020T3 ES89310778T ES89310778T ES2052020T3 ES 2052020 T3 ES2052020 T3 ES 2052020T3 ES 89310778 T ES89310778 T ES 89310778T ES 89310778 T ES89310778 T ES 89310778T ES 2052020 T3 ES2052020 T3 ES 2052020T3
Authority
ES
Spain
Prior art keywords
produce
production
anaerobic bacteria
antibiotics against
against anaerobic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES89310778T
Other languages
English (en)
Inventor
Tadashi Yoshida
Teruo Hattori
Koichi Matsumoto
Yoshihiro Terui
Junichi Shoji
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Shionogi and Co Ltd
Original Assignee
Shionogi and Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Shionogi and Co Ltd filed Critical Shionogi and Co Ltd
Application granted granted Critical
Publication of ES2052020T3 publication Critical patent/ES2052020T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/34—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/365—Lactones
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/34—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D307/56—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D307/60—Two oxygen atoms, e.g. succinic anhydride
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P17/00—Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms
    • C12P17/02—Oxygen as only ring hetero atoms
    • C12P17/04—Oxygen as only ring hetero atoms containing a five-membered hetero ring, e.g. griseofulvin, vitamin C
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/8215—Microorganisms
    • Y10S435/822—Microorganisms using bacteria or actinomycetales

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Engineering & Computer Science (AREA)
  • Health & Medical Sciences (AREA)
  • Zoology (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Microbiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biochemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)

Abstract

COMPUESTOS DE LA FORMULA (I) EN DONDE R ES
ES89310778T 1988-10-20 1989-10-19 Antibioticos efectivos frente a bacterias anaerobias, su produccion y utilizacion y cepas de enterobacter productoras de los mismos. Expired - Lifetime ES2052020T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP26657588 1988-10-20

Publications (1)

Publication Number Publication Date
ES2052020T3 true ES2052020T3 (es) 1994-07-01

Family

ID=17432717

Family Applications (1)

Application Number Title Priority Date Filing Date
ES89310778T Expired - Lifetime ES2052020T3 (es) 1988-10-20 1989-10-19 Antibioticos efectivos frente a bacterias anaerobias, su produccion y utilizacion y cepas de enterobacter productoras de los mismos.

Country Status (7)

Country Link
US (1) US5045458A (es)
EP (1) EP0365329B1 (es)
KR (1) KR970005488B1 (es)
AT (1) ATE73789T1 (es)
DE (1) DE68901024D1 (es)
ES (1) ES2052020T3 (es)
GR (1) GR3004095T3 (es)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR970005488B1 (ko) * 1988-10-20 1997-04-16 시오노 기세이야꾸 가부시끼가이샤 항생제 pb-6042류
WO1993004055A2 (en) * 1991-08-27 1993-03-04 The Upjohn Company Compounds used for the inhibition of hiv-protease
CA2168757A1 (en) * 1993-09-17 1995-03-23 Robert A. Chrusciel Substituted tetronic acids useful for treating hiv and other retroviruses
AU5417696A (en) * 1995-03-20 1996-10-08 Upjohn Company, The Substituted tetronic acids useful for treating hiv and other retroviruses

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS60258173A (ja) * 1984-06-01 1985-12-20 Kanegafuchi Chem Ind Co Ltd ａ−〔３−タ−シヤリ−ブチル−５−（１，１−ジメチル−２−ヒドロキシエチル）−４−ヒドロキシベンジリデン〕−γ−ブチロラクトンおよびその製造法並びにそれを有効成分とする抗炎症剤および血小板凝集阻害剤
JPS6471867A (en) * 1987-09-11 1989-03-16 Taisho Pharmaceutical Co Ltd Propionic acid compound
JPH01227355A (ja) * 1988-03-11 1989-09-11 Sanyo Electric Co Ltd 非水電解液電池
DE3813806A1 (de) * 1988-04-23 1989-11-02 Basf Ag 11-hydroxy-(gamma)-dodecalacton und seine herstellung
KR970005488B1 (ko) * 1988-10-20 1997-04-16 시오노 기세이야꾸 가부시끼가이샤 항생제 pb-6042류
JPH0396182A (ja) * 1989-09-08 1991-04-22 Citizen Watch Co Ltd 液晶テレビジョンの表示方式

Also Published As

Publication number Publication date
EP0365329A2 (en) 1990-04-25
KR900006517A (ko) 1990-05-08
DE68901024D1 (de) 1992-04-23
EP0365329A3 (en) 1990-08-29
ATE73789T1 (de) 1992-04-15
GR3004095T3 (es) 1993-03-31
KR970005488B1 (ko) 1997-04-16
US5045458A (en) 1991-09-03
EP0365329B1 (en) 1992-03-18

Similar Documents

Publication Publication Date Title
ATE30591T1 (de) Totalsynthese von antitumorantibiotika.
AU584388B2 (en) Novel heterocyclic compounds
GT198065892A (es) Derivados de acidos 6 b-hidroxialquilpenicilanicos como inhibidores de b-lactamasa.
DK0944643T3 (da) Oxyiminopregnancarbolactoner.
FI854089L (fi) Syntetiska kalciumsilikat, foerfarande foer deras framstaellning och deras anvaendningar.
ES2042868T3 (es) Un metodo de producir galidermina.
CA1266247C (en) ANTIBIOTIC PREPARED BY LYSOBACTER SP. SC14.067
ES2039230T3 (es) Procedimiento para preparar antibioticos glicopeptidicos.
ES2052020T3 (es) Antibioticos efectivos frente a bacterias anaerobias, su produccion y utilizacion y cepas de enterobacter productoras de los mismos.
FI832592A (fi) Foerfarande foer att utfoera elektromikrobiella reduktioner
IT8267997A0 (it) Procedimento e microrganismi per laproduzione della l lisina mediante fermentazione
FI860074A0 (fi) Oktahydroindolizinfoereningar anvaendbara som smaertstillande medel.
DE3687100T2 (de) Clavamderivate, herstellung und zwischenprodukte.
SE8402619D0 (sv) Bbm-1675, a new antitumor antibiotic complex
FR2630128B1 (fr) Boites de culture simultanee de micro-organismes aerobies et anaerobies
FR2608169B1 (fr) Module de culture de micro-organismes
ES2093984T3 (es) Procedimiento para la obtencion fermentativa de acido 2-hidroxifenilacetico.
ES471709A1 (es) Un procedimiento microbiologico para la preparacion de un nuevo complejo antibiotico
BE797862A (en) Pepsinostreptin and pepsinostreptin-p and their methyl - esters - protease inhibitors used to treat ulcers, hyperpepsia, hyper
ES2038601T3 (es) Procedimiento para preparar 4-androsten-3,17-diona y 1,4-androstadien-3,17-diona.
TR24538A (tr) Streptomyces mikroorganizmalarinin fermentasyonuy- la elde edilen yeni makrolid
SU815985A1 (ru) Бактерицид
MX9207565A (es) Hidroxilacion.
SU1351063A1 (ru) Производные 2-тиазолзамещенного 5-нитрофурана, проявляющие антистафилококковую активность
ES8606271A1 (es) Procedimiento de preparacion de sulfonamidas con agrupacion imido

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 365329

Country of ref document: ES